| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Lechleider Robert is a Chief Medical Officer at IMNM. Recent filings cover 1 purchase and 5 sales.
Our model assigns Lechleider Robert a strong insider score of 76/100, based on 3 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +96.7%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | IMNM Immunome, Inc. | Chief Medical Officer | Sale+OE10b5-1 | 55,000 | $22.62 | $1,244,330.62 | -77.7% | -8.9% | - | |
| Jun 25, 2026 | IMNM Immunome, Inc. | Chief Medical Officer | Sale+OE10b5-1 | 55,000 | $19.85 | $1,091,662.00 | -77.7% | +24.9% | - | |
| Nov 21, 2024 | IMNM Immunome Inc. | Chief Medical Officer | Buy | 15,805 | $9.48 | $149,799.79 | New | +5.1% | +96.7% |